| Pharmaceutical active ingredients: |
| Loratadine |
| Available forms, composition and doses of Clarityne Dy Repetabs: |
| Tablets, Extended Release; Oral; Loratadine 5 mg; Pseudoephedrine Sulfate 120 mg |
| Clarityne Dy Repetabs medical category: |
| Human:Antihistamines second generationAntiallergics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R06AX13 - Loratadine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Schering-Plough |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Clarityne | Loratadine | Schering-Plough; Agencia Lei Va Hong; Essex; Merck; Zuellig Pharma |
| Clarityne Cort | Betamethasone; Loratadine | Schering-Plough |
| Clarityne D | Loratadine; Pseudoephedrine Sulfate | Schering-Plough |
| Clarityne D Pediatrico | Loratadine; Pseudoephedrine Sulfate | Schering-Plough |
| Clarityne D Repetabs | Loratadine | Schering-Plough |
| Clarivir | Clarithromycin | East African India Overseas |
| Clarivit | Naphazoline | Vitapan Industria Farmaceutica |
| Clariwin | Clarithromycin | Micro Labs; Brown & Burk Pharmaceuticals |
| Clarix | Erysimum dry extract; Pholcodine | Cooperation Pharmaceutique Francaise |
| Clarix | Oxymetazoline Hydrochloride | L.O. Oftalmi Laboratorios |